Compare Abbott India with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SUVEN LIFESCIENCES - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SUVEN LIFESCIENCES ABBOTT INDIA/
SUVEN LIFESCIENCES
 
P/E (TTM) x 54.7 3.9 1,389.4% View Chart
P/BV x 16.1 0.6 2,783.9% View Chart
Dividend Yield % 0.4 4.0 10.8%  

Financials

 ABBOTT INDIA   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
SUVEN LIFESCIENCES
Mar-19
ABBOTT INDIA/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs8,834338 2,616.0%   
Low Rs5,458169 3,221.7%   
Sales per share (Unadj.) Rs1,731.152.1 3,320.8%  
Earnings per share (Unadj.) Rs211.96.8 3,102.5%  
Cash flow per share (Unadj.) Rs219.98.6 2,565.7%  
Dividends per share (Unadj.) Rs65.001.50 4,333.3%  
Dividend yield (eoy) %0.90.6 153.8%  
Book value per share (Unadj.) Rs945.265.3 1,447.8%  
Shares outstanding (eoy) m21.25127.28 16.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.14.9 84.9%   
Avg P/E ratio x33.737.1 90.8%  
P/CF ratio (eoy) x32.529.6 109.8%  
Price / Book Value ratio x7.63.9 194.7%  
Dividend payout %30.722.0 139.7%   
Avg Mkt Cap Rs m151,84832,272 470.5%   
No. of employees `0003.51.1 322.1%   
Total wages/salary Rs m4,356661 658.8%   
Avg. sales/employee Rs Th10,555.56,132.2 172.1%   
Avg. wages/employee Rs Th1,249.9611.1 204.5%   
Avg. net profit/employee Rs Th1,292.2803.5 160.8%   
INCOME DATA
Net Sales Rs m36,7866,635 554.4%  
Other income Rs m1,133242 467.6%   
Total revenues Rs m37,9196,877 551.4%   
Gross profit Rs m6,0471,604 377.0%  
Depreciation Rs m169221 76.4%   
Interest Rs m2338 59.7%   
Profit before tax Rs m6,9891,587 440.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,485718 346.1%   
Profit after tax Rs m4,503869 518.0%  
Gross profit margin %16.424.2 68.0%  
Effective tax rate %35.645.2 78.6%   
Net profit margin %12.213.1 93.4%  
BALANCE SHEET DATA
Current assets Rs m27,6106,232 443.0%   
Current liabilities Rs m8,5691,490 575.1%   
Net working cap to sales %51.871.5 72.4%  
Current ratio x3.24.2 77.0%  
Inventory Days Days6086 69.7%  
Debtors Days Days2783 33.2%  
Net fixed assets Rs m1,0574,043 26.1%   
Share capital Rs m213127 166.9%   
"Free" reserves Rs m19,8738,183 242.9%   
Net worth Rs m20,0868,310 241.7%   
Long term debt Rs m018 0.0%   
Total assets Rs m29,40910,389 283.1%  
Interest coverage x311.643.1 722.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.6 195.9%   
Return on assets %15.48.7 176.2%  
Return on equity %22.410.5 214.3%  
Return on capital %34.919.5 178.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3695,622 6.6%   
Fx outflow Rs m4,9181,799 273.3%   
Net fx Rs m-4,5493,822 -119.0%   
CASH FLOW
From Operations Rs m4,991356 1,404.0%  
From Investments Rs m-2,570-279 922.5%  
From Financial Activity Rs m-1,428-225 634.4%  
Net Cashflow Rs m993-148 -670.2%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 36.5 46.8%  
Shareholders   18,270 37,287 49.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

June WPI Inflation Data, IPO Buzz, and Top Stocks in Action Today(Pre-Open)

On Tuesday, Indian share markets fell sharply, led by weak Asian equities as worries of new lockdowns to stem surging coronavirus cases kept investors cautious worldwide.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

How We Made 10%+ Profits Overnight(Fast Profits Daily)

Jul 3, 2020

A simple trade in natural gas delivered more than 10% overnight. Here's how we did it...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jul 14, 2020 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - TTK HEALTHCARE COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS